Matthew Jester

Matthew Jester is an Investment Banking Analyst at Leerink Partners, specializing in biopharma, since July 2024. Prior to this role, Matthew served as a Business Development Associate at Natrion from November 2021 to May 2024 and completed a summer internship as an Investment Banking Summer Analyst at Leerink Partners in June to August 2023. Matthew also gained experience as an Analyst Extern at Battery Ventures from September 2022 to January 2023 and as an Analyst at Jumpstart Health Investors from May 2022 to August 2022. Matthew holds a Bachelor of Engineering in Bioengineering and Biomedical Engineering from the University of Pennsylvania, where study was completed from August 2020 to May 2024, and graduated from Greenwich High School in June 2020.